PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.76
ESG score 90-95% of MDGL's 66.37. Bill Ackman would demand clear ESG improvement catalysts.
59.57
Environmental score 90-95% of MDGL's 63.53. Bill Ackman would demand clear environmental improvement catalysts.
59.91
Social score 80-90% of MDGL's 69.00. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
59.79
Governance score 80-90% of MDGL's 66.59. Walter Schloss would scrutinize management accountability and board independence.